In previous studies, the prevalence of BRAF V600E mutation was 40%–50% in Caucasian papillary thyroid carcinoma (PTC) patients,4 and ranged from 72%–81% in Asian PTC patients.5 The gene discussed is BRAF; the disease is differentiated thyroid carcinoma.